# The Biologics Contract Manufacturing Demand Market to encapsulate digitization
Author:  Pal Sinha, Barnali 
Author URL: https://financedigest.com/author/pal-sinha-barnali
Published: 2021-11-17
Category: Research Reports
Category URL: https://financedigest.com/category/research-reports
Meta Title: Global Biologics Contract Manufacturing Demand Outlook 2030
Meta Description: Discover the growth potential of the biologics contract manufacturing demand market with key insights on digital convergence, outsourcing trends, and the
URL: https://financedigest.com/the-biologics-contract-manufacturing-demand-market-to-encapsulate-digitizationhtml

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/research-report-2-1736837256044-compressed.jpg)

The Biologics [Contract](https://www.financedigest.com/monte-dei-paschi-to-have-underwriting-consortium-for-share-sale-by-tuesday-source.html) Manufacturing Demand Market is expected to grow by leaps and bounds In Upcoming Years. With digital convergence coming across as a pivot, the entire ecosystem inclusive of OEMs, providers, payers, and various other intermediaries is in the orbit. These value-based, end-user-centric models are the focal point. SMAC and IoT are being leveraged to [build scalable connected digital platforms](https://www.financedigest.com/lending-stream-builds-leading-edge-credit-platform-with-fico-analytic-software.html "Lending Stream Builds Leading-Edge Credit Platform with FICO Analytic Software"). This is the running [trend and is expected](https://www.financedigest.com/what-to-expect-in-2022-financial-services-trends-according-to-salesforce.html "What to expect in 2022? Financial Services Trends, according to Salesforce") to be in continuation in the forecast period.

Pharmaceuticals and biotechnology companies are outsourcing specific services from the [early stages](https://www.financedigest.com/valuing-your-early-stage-startup.html "Valuing your Early Stage Startup") of drug development to biological contract manufacturing organizations to reduce drug manufacturing costs. Outsourcing increases drug manufacturing efficiency and facilitates flexible operational capabilities, which is expected to immensely boost [**biologics contract manufacturing demand**](https://www.persistencemarketresearch.com/market-research/biologics-contract-manufacturing-demand.asp). Rising prevalence of chronic and lifestyle diseases is also anticipated to propel biologics contract manufacturing demand. Besides, continuous [focus by manufacturers toward adopting technologically-advanced systems to manufacture](https://www.financedigest.com/why-manufacturers-mustnt-lose-their-green-focus-in-troubled-times.html "WHY MANUFACTURERS MUSTN’T LOSE THEIR GREEN FOCUS IN TROUBLED TIMES") novel biologics is also expected to accelerate the demand for biologics contract manufacturing over the forecast period.

**Get Sample Copy of this Report@** [**https://www.persistencemarketresearch.com/samples/31928**](https://www.persistencemarketresearch.com/samples/31928)

[Global biologics contract manufacturing demand is expected to reach](https://www.financedigest.com/artificial-intelligence-goes-global-demand-for-ai-reaches-four-continents-in-three-months-new-figures-from-synechron-show.html "Artificial Intelligence goes global: demand for AI reaches four continents in three months, new figures from Synechron show") at **8 Mn liters** (MnL) in **2030**, exhibiting an impressive **CAGR of over 17%** during the forecast period ( **2020**– **2030**).

**Company Profiles:**

- BioXcellence (Boehringer Ingelheim GmbH)
- Lonza Group AG
- Samsung Biologics Co. Ltd.
- Fujifilm Diosynth Biotechnologies (FUJIFILM Holdings)
- AbbVie Contract Manufacturing (AbbVie Inc.)
- WuXi Biologics (Cayman) Inc.
- Patheon N.V. (Thermo Fisher Scientific Inc.)
- Emergent BioSolutions Inc.
- AGC Biologics
- Ajinomoto Bio-Pharma (Ajinomoto Co., Inc.)
- Avid Bioservices, Inc.
- KBI Biopharma (JSR Life Sciences (JLS))
- Catalent Inc.
- Abzena Plc.

**Get A Customized Scope To Match Your Need Ask An Expert –** [**sales@persistencemarketresearch.com**](mailto:sales@persistencemarketresearch.com)

**Request for Methodology@** [**https://www.persistencemarketresearch.com/methodology/31928**](https://www.persistencemarketresearch.com/methodology/31928)

**[Key Takeaways from Biologics Contract Manufacturing Demand](https://www.financedigest.com/screenless-display-market-demands-top-key-players-industry-analysis-and-forecast-2027.html "Screenless Display Market: Demands, Top Key Players, Industry Analysis And Forecast 2027") Study**

- Leading [global CDMOs are focusing on expansion](https://www.financedigest.com/q-acoustics-push-global-expansion-with-canada-launch.html "Q Acoustics Push Global Expansion with Canada Launch") of their manufacturing capabilities with high flexibility and rapid operation capacity as biologics contract manufacturing demand is high. With the help of advanced single-use technologies, companies are able to [cut batch manufacturing and cleaning time](https://www.financedigest.com/britains-purplebricks-to-cut-more-than-10-of-jobs-the-times.html "Britain’s Purplebricks to cut more than 10% of jobs – The Times") from 7 days to 1 day. This trend is expected to provide a competitive-edge to companies in terms of capacity, cost, convenience, and operational efficacy.
  - For instance, in **Oct 2018**, Thermo Fisher Scientific Inc. announced a **US$ 50 million** (€44 million) expansion at a CDMO plant in St Louis, Missouri, U.S., to add **16,000** L of single-use capacity due to extremely strong [growth in demand](https://www.financedigest.com/digital-ad-demand-helps-publicis-hike-2021-growth-outlook.html "Digital ad demand helps Publicis hike 2021 growth outlook") for commercial biologic manufacturing. As per the company, the facility will be the largest outsourced single-use biologics site in North America.
- With [advancements in contract solutions](https://www.financedigest.com/redpalm-enhances-client-engagement-with-vias-advanced-call-routing-solution.html "REDPALM ENHANCES CLIENT ENGAGEMENT WITH VIA’S ADVANCED CALL ROUTING SOLUTION "), leading CDMOs are focusing on the expansion of their integrated capabilities from molecule-to-finished product. This trend is significant as the acceleration of development and speed to [market](https://www.financedigest.com/truck-mounted-concrete-mixer-market-notable-developments-geographical-outlook.html "Truck Mounted Concrete Mixer Market: Notable Developments & Geographical Outlook") is becoming more crucial for biopharmaceutical therapeutic developers.
  - For example, in **July 2020**, Avid [Bioservices and Argonaut Manufacturing Services entered into an agreement to offer biotechnology and pharmaceutical clients](https://www.financedigest.com/bny-mellon-strengthens-support-for-treasury-services-clients-in-germany-with-appointment-of-gungor-taner.html "BNY MELLON STRENGTHENS SUPPORT FOR TREASURY SERVICES CLIENTS IN GERMANY WITH APPOINTMENT OF GÜNGÖR TANER") integrated process development, drug substance manufacturing, and drug product parenteral manufacturing, to accelerate the development and commercialization of biopharmaceutical therapeutics.
- Viral vector and vaccines contract development and [manufacturing services are expected](https://www.financedigest.com/uk-manufacturers-expect-output-to-fall-3-2-in-2023.html "UK manufacturers expect output to fall 3.2% in 2023") to gain significant traction due to the **COVID-19** pandemic breakout and subsequent vaccine development programs.
  - For instance, in **June 2020**, AGC Biologics expanded its development capacities for pDNA services at the Heidelberg site, Germany, to meet the growing need for process development and manufacturing for plasmid DNA (pDNA).
- Europe is expected to be the most lucrative region and with a revenue share of around one-third in [global biologics contract manufacturing demand](https://www.financedigest.com/global-factory-activity-weakens-as-demand-falters.html "Global factory activity weakens as demand falters") in **2020**, owing to the presence of leading CDMO facilities in the region.

**_“Technological advancements to improve the [manufacturing](https://www.financedigest.com/technology-skills-and-servitization-a-brighter-future-for-manufacturing.html "TECHNOLOGY, SKILLS AND SERVITIZATION: A BRIGHTER FUTURE FOR MANUFACTURING?") efficiency of biologics at low cost is expected to flourish market growth opportunities and provide a competitive advantage to market players in terms of innovation,”_** says a PMR analyst.

**Access Full Report@** [**https://www.persistencemarketresearch.com/checkout/31928**](https://www.persistencemarketresearch.com/checkout/31928)

**[Doubling Industry Capacity](https://www.financedigest.com/varo-energy-buys-80-of-dutch-biogas-firm-aims-to-double-capacity-by-2026.html "Varo Energy buys 80% of Dutch biogas firm; aims to double capacity by 2026") by 2022-2023 amid COVID-19 Pandemic**

[The](https://www.financedigest.com/recovery-bus-provides-cool-relief-for-s-koreas-covid-19-testers.html "‘Recovery bus’ provides cool relief for S.Korea’s COVID-19 testers")**COVID-19** pandemic is becoming an industry changing milestone by providing opportunities to global CDMOs – small as well big CDMO companies. Local government and industry funds are being targeted toward rapid expansion of industry capacity in order to meet the unmet [demand for vaccine development and commercialization amid](https://www.financedigest.com/novavax-cuts-full-year-revenue-forecast-again-amid-weak-demand.html "Novavax cuts full-year revenue forecast again amid weak demand") the **COVID-19** crisis.

For instance, in **June 2020**, Fujifilm Diosynth Biotechnologies announced the [investment of 100 billion](https://www.financedigest.com/toyota-motor-to-invest-5-3-billion-in-japan-u-s-for-ev-battery-supply.html "Toyota Motor to invest .3 billion in Japan, U.S. for EV battery supply") Yen (US$ 928 Million) to expand its large-scale biologics production facility in Denmark.

**Expansion of Manufacturing Capacity – Imperative Strategy for Market Players**

Key players involved in biologics [contract manufacturing are looking forward to expand](https://www.financedigest.com/incentive-qas-expands-retail-portfolio-with-million-pound-shopping-centre-contract.html "Incentive QAS Expands Retail Portfolio With Million Pound Shopping Centre Contract") their manufacturing capacities to meet global demand. Leading companies are expanding their production capabilities and capacities to become the preferred choice for [innovative biopharmaceutical companies and hold on to a strong position in the market](https://www.financedigest.com/the-date-syrup-market-to-fathom-the-depth-of-innovation.html "The Date Syrup Market To Fathom The Depth Of Innovation").

For instance, in **January 2019**, Boehringer Ingelheim Biopharmaceuticals China expanded its commercial manufacturing capacities. The company installed an additional bioreactor, all needed utility, and infrastructure for GMP operations.

**What Does the Report Cover?**

Persistence Market Research offers a unique perspective and actionable insights on [biologics](https://www.financedigest.com/the-glucose-analysis-tubes-market-to-keep-up-the-digitized-momentum.html) contract manufacturing demand in its latest study, presenting historical demand assessment of **2015**– **2019** and projections for **2020** – **2030**, on the basis of platform (mammalian and microbial), application (commercial and clinical) product (monoclonal antibodies, recombinant proteins, vaccines, insulin, interferons, growth factors, and others), and therapeutic area (oncology, autoimmune disease, metabolic disease, ophthalmology, cardiovascular disease, infectious disease, neurology, respiratory disorders, and others), across seven key regions.

**Related Reports:**

[**Post Herpetic Neuralgia Treatment Market**](https://www.persistencemarketresearch.com/market-research/post-herpetic-neuralgia-treatment-market.asp)

[**Ankle Syndesmosis Treatment Devices Market**](https://www.persistencemarketresearch.com/market-research/ankle-syndesmosis-treatment-devices-market.asp)

**About Us:** [**Persistence Market Research**](https://www.persistencemarketresearch.com/about-us.asp)

**Contact Us:**

**Persistence Market Research**

Address – 305 Broadway, 7th Floor, New York City,

NY 10007 United States

U.S. Ph. – +1-646-568-7751

USA-Canada Toll-free – +1 800-961-0353

**Japan Office:** 1-2-1 Kinshi Arca Central Building

14/F Tokyo, 130-0013, Japan

Call 1-888-863-3700

**Sales** – sales@persistencemarketresearch.com

**Website** – [https://www.persistencemarketresearch.com](https://www.persistencemarketresearch.com/)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---